Zimmer thrives on R&D: New products account for 18 percent of sales

Abstract

Purpose

Highlights the importance of research and development to orthopedics company Zimmer.

Design/methodology/approach

Reports information gathered during the author's visit to a Zimmer plant in Winterthur, near Zurich, Switzerland, and a presentation to journalists by Richard Fritschi, Zimmer president (Europe and Australasia).

Findings

Shows that, in 2004, products introduced in the previous 36‐month rolling period accounted for 18 percent of Zimmer sales – up from 17 percent the year before. These new products contributed $541 in sales. In 2004 alone, Zimmer delivered more than 40 major development projects to the market. Describes some of the company's leading products and their uses.

Originality/value

Illustrates the key role of research and development for organizational success in the medical technology industries.

Citation

(2005), "Zimmer thrives on R&D: New products account for 18 percent of sales", Strategic Direction, Vol. 21 No. 9, pp. 21-23. https://doi.org/10.1108/02580540510616674